| Pharmacokinetics of monoclonal antibodies JT Ryman, B Meibohm CPT: pharmacometrics & systems pharmacology 6 (9), 576-588, 2017 | 730 | 2017 |
| How important are gender differences in pharmacokinetics? B Meibohm, I Beierle, H Derendorf Clinical pharmacokinetics 41, 329-342, 2002 | 588 | 2002 |
| Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function MS Artigas, DW Loth, LV Wain, SA Gharib, M Obeidat, W Tang, G Zhai, ... Nature genetics 43 (11), 1082-1090, 2011 | 480 | 2011 |
| Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives H Derendorf, B Meibohm Pharmaceutical research 16, 176-185, 1999 | 473 | 1999 |
| Population pharmacokinetics of therapeutic monoclonal antibodies NL Dirks, B Meibohm Clinical pharmacokinetics 49, 633-659, 2010 | 470 | 2010 |
| Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling B Meibohm, H Derendorf International journal of clinical pharmacology and therapeutics 35 (10), 401-413, 1997 | 426 | 1997 |
| Pharmacokinetic aspects of biotechnology products L Tang, AM Persky, G Hochhaus, B Meibohm Journal of pharmaceutical sciences 93 (9), 2184-2204, 2004 | 392 | 2004 |
| Immunogenicity to therapeutic proteins: impact on PK/PD and efficacy N Chirmule, V Jawa, B Meibohm The AAPS journal 14, 296-302, 2012 | 335 | 2012 |
| Pharmacokinetics and pharmacokinetic–pharmacodynamic correlations of therapeutic peptides L Diao, B Meibohm Clinical pharmacokinetics 52, 855-868, 2013 | 331 | 2013 |
| Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers SU Mertens-Talcott, J Rios, P Jilma-Stohlawetz, LA Pacheco-Palencia, ... Journal of agricultural and food chemistry 56 (17), 7796-7802, 2008 | 315 | 2008 |
| Gender differences in pharmacokinetics and pharmacodynamics. I Beierle, B Meibohm, H Derendorf International journal of clinical pharmacology and therapeutics 37 (11), 529-547, 1999 | 295 | 1999 |
| Genetic ancestry in lung-function predictions R Kumar, MA Seibold, MC Aldrich, LK Williams, AP Reiner, L Colangelo, ... New England Journal of Medicine 363 (4), 321-330, 2010 | 285 | 2010 |
| Pharmacokinetics and pharmacodynamics of inhaled corticosteroids H Derendorf, G Hochhaus, B Meibohm, H Möllmann, J Barth Journal of Allergy and Clinical Immunology 101 (4), S440-S446, 1998 | 259 | 1998 |
| Genome-Wide Association Studies Identify CHRNA5/3 and HTR4 in the Development of Airflow Obstruction JB Wilk, NRG Shrine, LR Loehr, JH Zhao, A Manichaikul, LM Lopez, ... American journal of respiratory and critical care medicine 186 (7), 622-632, 2012 | 231 | 2012 |
| Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters S Läer, TS Mir, F Behn, M Eiselt, H Scholz, A Venzke, B Meibohm, J Weil American heart journal 143 (5), 916-922, 2002 | 229 | 2002 |
| The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients CR Yates, W Zhang, P Song, S Li, AO Gaber, M Kotb, MR Honaker, ... The Journal of Clinical Pharmacology 43 (6), 555-564, 2003 | 216 | 2003 |
| The clinical pharmacokinetics of phosphodiesterase‐5 inhibitors for erectile dysfunction M Gupta, A Kovar, B Meibohm The Journal of Clinical Pharmacology 45 (9), 987-1003, 2005 | 212 | 2005 |
| Physiologically based pharmacokinetic (PBPK) modeling in children JS Barrett, O Della Casa Alberighi, S Läer, B Meibohm Clinical Pharmacology & Therapeutics 92 (1), 40-49, 2012 | 211 | 2012 |
| Population pharmacokinetic studies in pediatrics: issues in design and analysis B Meibohm, S Läer, JC Panetta, JS Barrett The AAPS journal 7, E475-E487, 2005 | 211 | 2005 |
| The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy N Mehrotra, M Gupta, A Kovar, B Meibohm International journal of impotence research 19 (3), 253-264, 2007 | 198 | 2007 |
